TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

About Alex Nixon

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries


By Alex Nixon

Published: Thursday, Nov. 29, 2012, 12:40 p.m.

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. UPMC to city: Try to tax our subsidiaries
  2. Starkey: Fleury’s future at stake
  3. Obama hopes to replicate CCAC job training efforts across U.S.
  4. Cueto gets best of Bucs, as Reds take series
  5. Connellsville area benefits from tourism grant program
  6. Authorities plan to withdraw charge against bullied South Fayette student
  7. Bruce Springsteen and The E Street Band to play Consol on April 22
  8. New Castle woman pleads guilty in pursuit death of police officer
  9. Bassist McBride stresses attitude for jazz hopefuls
  10. Jailed Hribal ‘fine,’ but family ‘terrible’ as answers in stabbing sought
  11. Police: Volunteer firefighter admits to setting fires
Subscribe today! Click here for our subscription offers.